BioSpace News Archive

Collaboration planned to develop therapeutics potentially targeting multiple ophthalmic diseases leveraging APT’s PhageBank™ technology.

The global veterinary equipment and disposables market is expected to witness high growth in the near future, states Transparency Market Research in its recent report.

The global medical holography market features an extremely competitive market landscape with numerous market players focusing on the development of new products, reports Transparency Market Research.

In terms of revenue, the global ileostomy market is projected to expand at a CAGR of ~7% during the forecast period, due to numerous factors, about which, TMR offers comprehensive insights and forecasts in the global Ileostomy market report.

Healthcare credentialing software or platform simplifies & automates the process of insurance, vendor, and facility provider credentialing.

Transparency Market Research has published a new report titled ‘Cellulite Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026.’ According to the report, the global cellulite treatment market was valued at US$ 619.2 Mn in 2017.

Revolution Medicines, Inc., a clinical-stage precision oncology company developing targeted therapies to inhibit frontier targets in RAS-addicted cancers, announced that it will host a Science Talk webcast to highlight learnings from recent preclinical and clinical studies of RAS inhibitors.

FluroTech LTD. and wholly owned subsidiary FluroTest Diagnostic Systems, a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, are pleased to announce the appointment of former U.S. Public Health Service and Four-Star Admiral Joxel Garcia, M.D. to Chief Medical Officer.

10x Genomics, Inc. announced it is shipping its new Visium Spatial Gene Expression for FFPE assay.

Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use, today announced that it will host an investor webinar on Wednesday, June 16, 2021, at 10:00 a.m. Eastern Time